June 28, 2012 - Thursday
PROSTATE CANCER
1. Prostate Cancer
a. Presentation: Prostate Cancer Screening: Do we need to change our approach?
b. Presentation: Prostate Biopsy: What is the best approach?
c. Panel: Prostate Cancer Pathology (Biopsy vs. Prostatectomy Specimens)
2. Prostate Cancer
a. Presentation: Imaging Techniques in Diagnosis and Staging
b. Presentations on Management of Low Risk Disease
1. Presentation: Active Surveillance
2. Presentation: Radical Prostatectomy
3. Presentation: Radiation Therapy (Brachytherapy, IMRT, use of Hormone Ablation)
4. Presentation: Cryoablation
5. Presentation: HIFU
6. Panel Discussion
3. Prostate Cancer
a. Presentation: Role of Lymphadenectomy in Clinically Organ-Confined Disease
b. Presentations on Management of Intermediate Risk Disease
1. Presentation: Open Radical Prostatectomy
2. Presentation: Laparoscopic and Robotic Radical Prostatectomy
3. Presentation: New Radiation-Based Modalities
4. Panel Discussion
4. Prostate Cancer
a. Presentation: Minimizing Sexual and Urinary Morbidities
b. Presentations on Management of Locally Advanced Disease
1. Presentation: What is the Management of Positive Surgical Margins and Seminal Vesical Invasion?
2. Presentation: What is the Role of Adjunctive Radiation in Locally Advanced Disease and Positive Margins?
3. Presentation: How should a Rising PSA following "Definitive" Therapy be Treated?
4. Panel Discussion
Symposium : Advanced Prostate Cancer:
Definition and Classification
Mechanisms and integration of new systemic therapies
News Agents and Indications for Bone Health in prostate cancer
Nutraceuticals and prostate cancer
Vaccines
Update on New Chemotherapy in hormone resistant disease
June 29, 2012 - Friday
BLADDER CANCER
I- BLADDER CANCER
CONFERENCE 9 : How to optimise the Management of non-muscle invasive bladder cancer?
CONFERENCE 10 : Urine markers are useful in the screening of bladder cancer
Module : Update on noninvasive disease
II – BLADDER CANCER
CONFERENCE 11 : Update on Pathology of bladder cancer
CONFERENCE 12 : Update of Imaging techniques in the diagnosis and staging of Bladder Cancer.
Module : Update on management of Invasive Bladder Cancer / Actualización en el manejo del cáncer de vejiga invasivo.
III – BLADDER CANCER
CONFERENCE 13 : Radical cystectomy con orthotopic neobladder for invasive bladder cancer: critical analysis of long term oncological, functional and quality of life results
Mini- Module: Advanced T4 stage bladder cancer: Patients benefit from the interdisciplinary approach:
Urology
Radiology
Oncology
Module: Management of the surgical candidate with invasive bladder cancer
Topics: clinical selection of the candidate - urethrectomy – Extension of lymphadenectomy - Selection of urinary derivation.
CONFERENCE 14 : New systemic treatment modalities in advanced bladder cancer.
CONFERENCE 15: Nutrition and Cancer
SYMPOSIUM: Novel Targeted therapy for advanced renal carcinoma:
trials in progress
June 30, 2012 - Saturday
RENAL CELL CARCINOMA
I – KIDNEY CANCER:
CONFERENCE 16 : Prognostic and Predictive Factors in Renal Cell Carcinoma.
CONFERENCE 17 : Genetic Basis of Kidney Cancer: Implications for diagnosis and magement.
Module: Small Renal Masses
Topics: Role of Biopsy in the diagnosis and treatment – Active surveillance – Parcial Nephectomy - oncologic outcome – renal function and survival – Impact of warn isquemia time
CONFERENCE 18 : New ablative techniques for localized RCC
II – KIDNEY CANCER:
CONFERENCE 19 : Update on Pathology of RCC
CONFERENCE 20 : Surgery for renal cell carcinoma metastases
CONFERENCE 21 : Prognostic and therapeutic implications of lymphadenectomy in RCC
Module: Advanced renal carcinoma treatment
Topics: The role of cytoreductive nephectomy - First-line and second- line therapy – Combination Therapy – Secquential therapy – Presurgical therapy and the role of nephectomy
CONFERENCE 22 : Factors affecting outcome in renal cell carcinoma
CONFERENCE 23 : Psychology and Quality of Life of cancer patients
PROBABLE COURSES:
1. Uro- oncological pathology : Joint sesion with Pathologists
2. Physiotherapy and Uro-oncology: Physiotherapists and Urologists
3. Future of Uro-onncology: Oncologists - Radiotherapists - Urologists - Radiologists, Psychologists - Pathologists
Click here to download the program
PROSTATE CANCER
1. Prostate Cancer
a. Presentation: Prostate Cancer Screening: Do we need to change our approach?
b. Presentation: Prostate Biopsy: What is the best approach?
c. Panel: Prostate Cancer Pathology (Biopsy vs. Prostatectomy Specimens)
2. Prostate Cancer
a. Presentation: Imaging Techniques in Diagnosis and Staging
b. Presentations on Management of Low Risk Disease
1. Presentation: Active Surveillance
2. Presentation: Radical Prostatectomy
3. Presentation: Radiation Therapy (Brachytherapy, IMRT, use of Hormone Ablation)
4. Presentation: Cryoablation
5. Presentation: HIFU
6. Panel Discussion
3. Prostate Cancer
a. Presentation: Role of Lymphadenectomy in Clinically Organ-Confined Disease
b. Presentations on Management of Intermediate Risk Disease
1. Presentation: Open Radical Prostatectomy
2. Presentation: Laparoscopic and Robotic Radical Prostatectomy
3. Presentation: New Radiation-Based Modalities
4. Panel Discussion
4. Prostate Cancer
a. Presentation: Minimizing Sexual and Urinary Morbidities
b. Presentations on Management of Locally Advanced Disease
1. Presentation: What is the Management of Positive Surgical Margins and Seminal Vesical Invasion?
2. Presentation: What is the Role of Adjunctive Radiation in Locally Advanced Disease and Positive Margins?
3. Presentation: How should a Rising PSA following "Definitive" Therapy be Treated?
4. Panel Discussion
Symposium : Advanced Prostate Cancer:
Definition and Classification
Mechanisms and integration of new systemic therapies
News Agents and Indications for Bone Health in prostate cancer
Nutraceuticals and prostate cancer
Vaccines
Update on New Chemotherapy in hormone resistant disease
June 29, 2012 - Friday
BLADDER CANCER
I- BLADDER CANCER
CONFERENCE 9 : How to optimise the Management of non-muscle invasive bladder cancer?
CONFERENCE 10 : Urine markers are useful in the screening of bladder cancer
Module : Update on noninvasive disease
II – BLADDER CANCER
CONFERENCE 11 : Update on Pathology of bladder cancer
CONFERENCE 12 : Update of Imaging techniques in the diagnosis and staging of Bladder Cancer.
Module : Update on management of Invasive Bladder Cancer / Actualización en el manejo del cáncer de vejiga invasivo.
III – BLADDER CANCER
CONFERENCE 13 : Radical cystectomy con orthotopic neobladder for invasive bladder cancer: critical analysis of long term oncological, functional and quality of life results
Mini- Module: Advanced T4 stage bladder cancer: Patients benefit from the interdisciplinary approach:
Urology
Radiology
Oncology
Module: Management of the surgical candidate with invasive bladder cancer
Topics: clinical selection of the candidate - urethrectomy – Extension of lymphadenectomy - Selection of urinary derivation.
CONFERENCE 14 : New systemic treatment modalities in advanced bladder cancer.
CONFERENCE 15: Nutrition and Cancer
SYMPOSIUM: Novel Targeted therapy for advanced renal carcinoma:
trials in progress
June 30, 2012 - Saturday
RENAL CELL CARCINOMA
I – KIDNEY CANCER:
CONFERENCE 16 : Prognostic and Predictive Factors in Renal Cell Carcinoma.
CONFERENCE 17 : Genetic Basis of Kidney Cancer: Implications for diagnosis and magement.
Module: Small Renal Masses
Topics: Role of Biopsy in the diagnosis and treatment – Active surveillance – Parcial Nephectomy - oncologic outcome – renal function and survival – Impact of warn isquemia time
CONFERENCE 18 : New ablative techniques for localized RCC
II – KIDNEY CANCER:
CONFERENCE 19 : Update on Pathology of RCC
CONFERENCE 20 : Surgery for renal cell carcinoma metastases
CONFERENCE 21 : Prognostic and therapeutic implications of lymphadenectomy in RCC
Module: Advanced renal carcinoma treatment
Topics: The role of cytoreductive nephectomy - First-line and second- line therapy – Combination Therapy – Secquential therapy – Presurgical therapy and the role of nephectomy
CONFERENCE 22 : Factors affecting outcome in renal cell carcinoma
CONFERENCE 23 : Psychology and Quality of Life of cancer patients
PROBABLE COURSES:
1. Uro- oncological pathology : Joint sesion with Pathologists
2. Physiotherapy and Uro-oncology: Physiotherapists and Urologists
3. Future of Uro-onncology: Oncologists - Radiotherapists - Urologists - Radiologists, Psychologists - Pathologists
Click here to download the program
